France· FR:67644397
NEORECORMON 5000 UI, solution injectable en seringue préremplie
A medicinal product containing époétine bêta, registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉPOÉTINE BÊTA
- Manufacturer
- ROCHE REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip1334009350031261 seringue(s) préremplie(s) en verre de 0,3 ml
- cip1334009350032946 seringue(s) préremplie(s) en verre de 0,3 mlEUR 124.74
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Époétine bêta in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEpoetin alfa Hexal 5000 IE, oplossing voor injectie (in voorgevulde spuit)Hexal Biotech Forschungs GmbH
- CzechiaABSEAMEDMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumAbseamed 1000 IU/0.5 mlMedice Arzneimittel Pütter
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
- SwedenAbseamed 10 000 IE/ 1 ml Injektionsvätska, lösning i förfylld sprutaMedice Arzneimittel Pütter GmbH & Co. KG
- PolandAbseamedMedice Arzneimittel Puetter GmbH & Co. KG
- IrelandAbseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.G
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Erypo
- Belgium · Eprex
- Czechia · Eprex
- Germany · Erypo Fs
- Spain · Eprex
- United Kingdom (Northern Ireland) · Eprex
- Greece · Eprex
- Iceland · Abseamed, Binocrit
- Italy · Eprex
- Liechtenstein · Binocrit, Epoetin Alfa Hexal
- Luxembourg · Eprex
- Netherlands · Eprex
- Norway · Abseamed, Binocrit
- Portugal · Eprex
- Slovenia · Eprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47523974-ea82-41ad-b945-01f638131b40 GET /v1/drugs/47523974-ea82-41ad-b945-01f638131b40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67644397",
"date_amm": "1998-04-02",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/97/031",
"substance": "ÉPOÉTINE BÊTA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about époétine bêta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.